3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Dermatologic
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
CNS
1
Breast
1
Conditions
Microsatellite Unstable Colorectal Cancer
1
Interventions
Nivolumab
3
Ipilimumab
3
pembrolizumab
2
entrectinib
2
cobimetinib
2
Pemetrexed
2
Cisplatin
2
tovorafenib
1
sotorasib
1
relatlimab
1
pralsetinib
1
larotrectinib
1
ipatasertib
1
inavolisib
1
daratumumab
1
atezolizumab
1
alectinib
1
PM 01183
1
Midazolam
1
Carboplatin
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
relatlimab
×
Other solid neoplasm
×
Clear all
NCT02060188
2025-11-06
CheckMate142
Bristol-Myers Squibb
Phase 2
Completed
385 enrolled
17 charts
2 FDA